India is a country with over 10 million cancer patients, data culled by TOI from QuintilesIMS, a technology-driven healthcare service provider shows. So, even as the oncology landscape is rapidly evolving with scientific advances in treatment options, many patients are being left untreated, with most health systems struggling to adapt to the change. In India, oncology treatment typically run into lakhs, particularly with certain lung, prostrate and breast cancer drugs priced over a lakh per dose in certain cases. Regulatory systems, diagnostics, treatment infrastructure, and financing mechanisms need to crank up to meet the needs of patients.
“Firms realise that there are medicines which are not broadly available in India due to a range of reasons, and that there is a need to be fully able to access the medicines being discovered and launched in other parts of the world,” says Amit Mookim, MD, South Asia QuintilesIMS.